Japanese Patent Granted for a Smart Drug Delivery Technology

Shanghai, China, September 10, 2016 – Broda Technologies Co., Ltd. today announced it has been granted Japanese Patent Registration No. 5980304 on August 5, 2016 for a Japanese patent titled “Reversely Thermal-Reversible Hydrogel Compositions”.

The patent covers the Company’s key IntelliGel supramolecular smart drug delivery technology and its applications in pharmaceutical, cosmetic and personal care products.

“The granting of Japanese patent for the supramolecular smart drug delivery technology broadens our market access in the global market, and will allow Broda Technologies to work with potential partners in Japan for the possible technology development and commercilazation of related products. IntelliGel smart supramolecular drug delivery technology has wide potential applications with enhanced efficacy, patient compliance, and safety compared with existing pharmaceutical and cosmetic products.” stated Broda Technologies’ President Dr. Shao Lu.

About Broda Technologies

Broda Technologies Co. Ltd. is a small technology company focus on supramolecular smart drug delivery technology. The Company’s proprietary IntelliGel smart supramolecular drug delivery system is capable of dissolving water insoluble or sparely soluble drugs with sustained release in a clear and transparent thermo-responsive hydrogel for enhanced efficacy, safety and patient’s compliance. For more information, please visit www.brodatech.com.

For more information contact:

Shao Lu, Ph.D.
Broda Technologies Co., Ltd.
Tel: +86 21 2022 5388
E-mail: info@brodatech.com